Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial
Direct Source Verification:
This story is aggregated from Reuters (reuters.com). Full reporting rights and copyright belong to the primary publisher.
Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial Reuters
Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial Reuters
Original Source
https://www.reuters.com/business/healthcare-pharmaceuticals/regeneron-drug-halves-muscle-loss-combination-with-novos-semaglutide-trial-2026-09-30/
